Anhui Huatai Chemical Co., Ltd.
2025 Independent Director Work Report
(George Wu)
As an independent director of Anhui Huatai Chemical Co., Ltd. (hereinafter referred to as "the Company") during my tenure on the sixth board of directors in 2025, I have diligently performed my duties in strict accordance with the Company Law, the Management Measures for Independent Directors of Listed Companies, the Self-Regulatory Guidelines for Listed Companies on the Shenzhen Stock Exchange No. 1 - Standardized Operations of Main Board Listed Companies, and other relevant laws, regulations, normative documents, as well as the Company’s Articles of Association and the Independent Director Work System. I have actively attended relevant meetings, carefully reviewed various proposals, fully exercised the role of independent directors and special committees, effectively safeguarded the interests of all shareholders, especially the legitimate rights and interests of minority shareholders, and promoted the standardized operation of the Company. Below is my report on the performance of my duties in 2025:
I. Basic Information
(1) Work Experience, Professional Background, and Concurrent Positions
I, George Wu, hold Chinese nationality and do not have permanent residency abroad. I have a bachelor's degree and am a certified public accountant. I have served successively as an auditor at Hebei Lixin Accounting Firm, project manager at Tianzhi International Accounting Firm, department head at Zhongzhun Accounting Firm, executive general manager of the investment banking department at Wealth Securities Co., Ltd., vice president, board secretary, and financial director at Ciming Health Checkup Management Group Co., Ltd.; I currently serve as the executive director and general manager of Beijing Zhongjin Taian Asset Management Co., Ltd., non-executive director of Yaboshi Medical Holdings Group Co., Ltd., non-executive director of Beijing Haijinge Pharmaceutical Technology Co., Ltd., non-executive director of Hongxi Medical Technology (Beijing) Co., Ltd., and independent director of Anhui Shuguang Chemical Group Co., Ltd. I have been serving as an independent director of the Company since June 2024.
(2) Independence Statement
During my tenure as an independent director of the Company in 2025, I conducted a self-examination and confirmed that I did not hold any position other than independent director in the Company, nor did I hold any position in the Company’s major shareholders. There are no interests or other relationships that may hinder my independent and objective judgment between myself and the Company or its major shareholders, and there are no circumstances affecting the independence of independent directors. I meet the relevant requirements for independence as stipulated in the Management Measures for Independent Directors of Listed Companies and the Self-Regulatory Guidelines for Listed Companies on the Shenzhen Stock Exchange No. 1 - Standardized Operations of Main Board Listed Companies.